Sites in India

ISS offers access to substantial patient populations seeking treatment at more than 1000 of India’s top research centers. Sites comply with all FDA, EMEA and local regulatory requirements and adhere to the same quality standards as our network of US sites. Experienced investigators and coordinators offer documented ICH-GCP training and India-GCP training, ensuring quality performance and FDA/EMEA submissible data for your clinical trials.

Patient Access

Home to 1.2 billion people, India offers substantial patient access and supports trial enrollment goals. Our sites are spread across 24 metropolitan areas, with investigators who are proven credible and enthusiastic drawing study participants from large cities and neighboring suburbs. Large healthcare facilities average 1,000 beds each and serve between 350 and 2,250 patients per month. With rapidly growing patient bases, these sites offer substantial access to:

Diverse demographics – Caucasian, African, Asian, and tribal populations
Treatment-naïve populations – three times that of the US and Europe
Virtually all disease states – 1st and 3rd world and tropical diseases

Trial Expertise

Using robust databases made up of epidemiology information and patient demographics from hospitals, we are able to identify sites that have the highest prevalence of patients in over 600 conditions and ensure a large patient pool for virtually any global trial.

Medical Specialty	% of Sites	# Sites	# PIs	# Trials	Average # pts/site/month
Cardiology	8.5%	70	138	460	2,250
Dermatology	8.3%	68	82	145	700
Endocrinology	10.6%	87	114	715	900
Gastroenterology	4.1%	34	44	140	700
Infectious Dis. / HIV	1.7%	14	14	56	350
Internal Medicine	10.3%	85	104	218	5,000
Nephrology	5.7%	47	63	88	900
Neuropsychiatry	14.7%	121	161	331	900
Oncology	10.0%	82	126	426	500
Opthalmology	4.7%	39	80	81	1,100
Orthopedics	6.3%	52	57	90	900
Pediatrics	4.4%	36	48	129	5,000
Pulmonary Diseases	6.4%	53	54	226	2,400
Surgery (general)	4.4%	36	50	11	3,000